Accelerate Diagnostics Inc. Stock
Accelerate Diagnostics Inc. dominated the market today, gaining €0.15 (11.190%).
Pros and Cons of Accelerate Diagnostics Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accelerate Diagnostics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Accelerate Diagnostics Inc. | 11.190% | 13.740% | -5.096% | -68.958% | -58.611% | -96.747% | -99.200% |
MicroVision Inc | 1.470% | 4.231% | 26.577% | -48.047% | -57.664% | -89.788% | 97.197% |
Fonar Corp. New | 1.300% | 0.000% | 1.961% | 4.698% | -11.864% | 7.586% | -18.682% |
Allscripts Healthcare | - | 0.000% | -3.614% | -31.034% | -13.514% | -31.034% | -17.797% |
Comments
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AXDX provided by MarketBeat
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AXDX provided by MarketBeat